✦ LIBER ✦

Addressing the questions of tomorrow: melphalan and new combinations as conditioning regimens before autologous hematopoietic progenitor cell transplantation in multiple myeloma

✍ Scribed by Martino, Massimo; Olivieri, Attilio; Offidani, Massimo; Vigna, Ernesto; Moscato, Tiziana; Fedele, Roberta; Montanari, Mauro; Console, Giuseppe; Gentile, Massimo; Messina, Giuseppe; Irrera, Giuseppe; Morabito, Fortunato

Book ID: 125547226
Publisher: Informa plc
Year: 2013
Tongue: English
Weight: 360 KB
Volume: 22
Category: Article
ISSN: 1354-3784
DOI: 10.1517/13543784.2013.788643

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Combination of high-dose melphalan and b

Combination of high-dose melphalan and bortezomib as conditioning regimen for autologous peripheral blood stem cell transplantation in multiple myeloma

✍ Toshihiro Miyamoto, Goichi Yoshimoto… 📂 Article 📅 2013 🏛 Carden Jennings Publishing 🌐 English ⚖ 253 KB

High-dose idarubicin, cyclophosphamide a

High-dose idarubicin, cyclophosphamide and melphalan as conditioning for autologous stem cell transplantation increases treatment-related mortality in patients with multiple myeloma: results of a randomised study

✍ R. Fenk; P. Schneider; M. Kropff; A. N. Huenerlituerkoglu; U. Steidl; C. Aul; B. 📂 Article 📅 2005 🏛 John Wiley and Sons 🌐 English ⚖ 123 KB

Melphalan 180 mg/m2 Can Be Safely Admini

Melphalan 180 mg/m2 Can Be Safely Administered As Conditioning Regimen before an Autologous Stem Cell Transplantation (ASCT) in Multiple Myeloma Patients with Creatinine Clearance 60 mL/min/1.73 m2 or Lower with Use of Palifermin for Cytoprotection: Results of a Phase I Trial

✍ Abidi, Muneer H.; Agarwal, Rishi; Ayash, Lois; Deol, Abhinav; Al-Kadhimi, Zaid; 📂 Article 📅 2012 🏛 Elsevier Science 🌐 English ⚖ 139 KB